Keywords: آنتیبادیهای Bispecific; Bispecific antibodies; FGFR1; KLB; Pharmaceutical impurities;
مقالات ISI آنتیبادیهای Bispecific (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آنتیبادیهای Bispecific; ADA; antidrug antibody; ALI/ARDS; acute lung injury/acute respiratory distress syndromes; Ab; antibody; ADC; antibody drug conjugate; ADCC; antigen-dependent cellular cytotoxicity; BAL; bronchoalveolar lavage; BsAbs; bispecific antibodies; CCL; CC chemoki
Keywords: آنتیبادیهای Bispecific; bsAb; bispecific antibody; CAR; chimeric antigen receptor; CDN; cyclic dinucleotides; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T-lymphocyte-associated protein 4; GM-CSF; granulocyte-monocyte colony stimulating factor; IR; irradiation; PD-1; Programm
Keywords: آنتیبادیهای Bispecific; Monoclonal antibodies (mAbs); Therapeutic antibodies; Biologicals; Biosimilars; Biobetters; Antibody engineering; Antibody drug conjugates (ADC); Bispecific antibodies; Manufacture; Degradation; Stability; Formulation;
Keywords: آنتیبادیهای Bispecific; blood–brain barrier; central nervous system disorders; brain drug delivery; recombinant antibodies; bispecific antibodies; molecular Trojan horses (MTH)
Bispecific antibodies in haematological malignancies
Keywords: آنتیبادیهای Bispecific; Bispecific antibodies; Bispecific t-cell engager; Blinatumomab; Cytokine release syndrome; Neurotoxicity; Acute lymphoblastic leukemia; Non-hodgkin lymphoma;
T cell engaging bispecific antibody (T-BsAb): From technology to therapeutics
Keywords: آنتیبادیهای Bispecific; CRS; cytokine release syndrome; CTL; cytotoxic T lymphocyte; EC50; half maximal effective concentration; Fc; fragment crystallizable; ICI; immune checkpoint inhibitor; pMHC; peptide-major histocompatibility complex; scFv; single chain variable fragment; T
Bispecific antibodies for cancer therapy: A review
Keywords: آنتیبادیهای Bispecific; ADCC; antibody-dependent cell-mediated cytotoxicity; AE; adverse events; ALL; acute lymphoblastic leukemia; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; B-ALL; B-cell acute lymphoblastic leukemia; BiTES; Bi-sp
Novel Immunotherapy Approaches in AML: Focus on Monoclonal Antibodies
Keywords: آنتیبادیهای Bispecific; Acute myeloid leukemia; Target antigens; Bispecific antibodies; Antibody-drug conjugates; Radioimmunotherapy;
Catch me if you can: Leukemia Escape after CD19-Directed T Cell Immunotherapies
Keywords: آنتیبادیهای Bispecific; Chimeric antigen receptor T cells; Blinatumomab; Bispecific antibodies; Adoptive cell therapy; dualCART; tanCAR; biCAR; CART19; CTL019; Leukemia;
Rationale for anti-CD137 cancer immunotherapy
Keywords: آنتیبادیهای Bispecific; Cancer immunotherapy; CD137; Tumour microenvironment; Monoclonal antibodies; CAR; Bispecific antibodies; Natural killer cells; Cytotoxic T cells;
Targeting CD138−/CD20+ Clonogenic Myeloma Precursor Cells Decreases These Cells and Induces Transferable Antimyeloma Immunity
Keywords: آنتیبادیهای Bispecific; Activated T cells; Bispecific antibodies; Multiple myeloma
Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas
Keywords: آنتیبادیهای Bispecific; Bispecific antibodies; Clinical trial; Gastrointestinal cancer; Pancreatic cancer; Pharmacokinetics;
Analysis and purification of IgG4 bispecific antibodies by a mixed-mode chromatography
Keywords: آنتیبادیهای Bispecific; IgG4; Half molecule exchange; Fab-arm exchange; Mixed-mode chromatography; Bispecific antibodies;
Solvent modulated linear pH gradient elution for the purification of conventional and bispecific antibodies: Modeling and application
Keywords: آنتیبادیهای Bispecific; Linear pH gradient elution; Solvent modulation; Monoclonal antibodies; Bispecific antibodies; Product-related impurities;
A new bispecific antibody targeting non-overlapping epitopes on IGF2: Design, in vitro characterization and pharmacokinetics in macaques
Keywords: آنتیبادیهای Bispecific; IGF ligand; Bispecific antibodies; Half-life; Cynomolgus macaques;
Rational design and generation of recombinant control reagents for bispecific antibodies through CDR mutagenesis
Keywords: آنتیبادیهای Bispecific; Bispecific antibodies; Complementarity determining regions; Epidermal growth factor receptor; Site-directed mutagenesis;
Generation of single-chain bispecific green fluorescent protein fusion antibodies for imaging of antibody-induced T cell synapses
Keywords: آنتیبادیهای Bispecific; Retargeting; Bispecific antibodies; Tumor immunology; La antigen; CD33
Targeting Cytomegalovirus-Infected Cells Using T Cells Armed with Anti-CD3 × Anti-CMV Bispecific Antibody
Keywords: آنتیبادیهای Bispecific; CMV; Activated T cells; Bispecific antibodies; Peripheral blood mononuclear cells; Immunotherapy; Cytogam®
Development of tetravalent IgG1 dual targeting IGF-1R-EGFR antibodies with potent tumor inhibition
Keywords: آنتیبادیهای Bispecific; Antibody engineering; Bispecific antibodies; Single chain Fv; IGF-1R; EGFR; GA201; R1507;
Unexpected recombinations in single chain bispecific anti-CD3–anti-CD33 antibodies can be avoided by a novel linker module
Keywords: آنتیبادیهای Bispecific; Redirecting T cells; Bispecific antibodies; AML; CD33; Helical linker
A novel perspective for an orphan problem: Old and new drugs for the medical management of malignant ascites
Keywords: آنتیبادیهای Bispecific; Malignant ascites; Paracentesis; Diuretics; Intraperitoneal chemotherapy; Bispecific antibodies; Antiangiogenetic agents; Biological therapies
Cancer therapy with engineered monoclonal antibodies
Keywords: آنتیبادیهای Bispecific; Monoclonal antibodies; ADCC; Immunotoxins; Conjugated antibodies; Fc receptors; Phage display; Bispecific antibodies; Single chains; Herceptin; Cetuximab; Rituximab
Bispecific and human disease-related anti-keratin rabbit monoclonal antibodies
Keywords: آنتیبادیهای Bispecific; IEF; isoelectric focusing; IF; intermediate filament; K; keratin; MAb; monoclonal antibodies; S or Ser; serine; OA; okadaic acid; p; phospho; PV; pervanadate; Intermediate filaments; Phosphorylation; Bispecific antibodies; Rabbit monoclonal antibody; Mole
Death receptor-mediated apoptosis in human malignant glioma cells: Modulation by the CD40/CD40L system
Keywords: آنتیبادیهای Bispecific; BHK; baby hamster kidney; CD40L; CD40 ligand; CD95L; CD95 ligand; CHX; cycloheximide; DEVD-amc; Asp-Glu-Val-Asp-7-amino-4-methylcoumarin; DISC; death-inducing signaling complex; DMEM; Dulbecco's Modified Eagle's Medium; DR4/5; death receptor 4/5; ECL; enh